Is Nivolumab included in medical insurance?

Nivolumab (Nivolumab) studies cancer cells that produce a protein called PD-L1. For some cancers, nivolumab can only be used if tests show the cancer cells are producing enough PD-L1. Nivolumab can be used alone or, for some cancers, with other cancer drugs such as cabozantinib, ipilimumab or platinum-based chemotherapy drugs. Nivolumab contains the active substance nivolumab.

Nivolumab is a prescription medicine used in adults to treat melanoma (a type of skin cancer), non-small cell lung cancer ((NSCLC; a type of lung cancer), advanced renal cell carcinoma (a type of kidney cancer), classical Hodgkin lymphoma (a cancer of lymphocytes (white blood cells)), squamous cell carcinoma of the head and neck (SCCHN), urothelial carcinoma (a cancer of the bladder and urethra), malignant pleural mesothelioma (a cancer of the lining of the lungs), colorectal cancer (a cancer of the colon or rectum (lower intestine) described as microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR)), squamous Esophageal cancer (cancer of the esophagus from the mouth to the stomach), esophageal cancer and gastroesophageal junction cancer (cancer of the junction of the stomach and esophagus), adenocarcinoma of the stomach, gastroesophageal junction, or esophagus after chemotherapy, radiation therapy, and surgery

The generic drug Nivolumab is currently on the market in China, but it has not yet been included in medical insurance. This drug is a strictly controlled drug, and its purchase channels are restricted. Specifications The price of each box of 40mg/4ml may be around RMB 4,000. The Turkish version of the nivolumab generic drug listed overseas may cost more than RMB 2,000 per box of 40mg/4ml (the price may fluctuate due to exchange rates). Currently, there is no generic version of nivolumab available on the market. For more drug information and specific prices, please consult a medical consultant.